Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Urinary Bladder Neoplasms 5Breast Neoplasms 3Urothelial Cancer 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasm Metastasis 1Locally Advanced or Metastatic Unresectable Urothelial Cancer 1Carcinoma, Transitional Cell 1

Interventions

Dexamethasone 28Rituximab 16pomalidomide 14Gemcitabine 12Bortezomib 12Lenalidomide 11Cisplatin 11Paclitaxel 10Cyclophosphamide 8Carboplatin 8carfilzomib 7daratumumab 6selinexor 5Drug Therapy 5Doxorubicin 5Cytarabine 5ibrutinib 4Vincristine 4Temozolomide 4Prednisone 4Docetaxel 4Calcium Dobesilate 4Bevacizumab 4Aspirin 4tisagenlecleucel 3Injections 3Cetuximab 3Bendamustine Hydrochloride 3venetoclax 2ofatumumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Recurrence × vinflunine × Clear all
NCT02347332 2019-03-05

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Pierre Fabre Medicament

Phase 3 Completed
459 enrolled 13 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡